首页> 中文期刊> 《医学理论与实践》 >粤西地区幽门螺杆菌对抗生素耐药分析

粤西地区幽门螺杆菌对抗生素耐药分析

         

摘要

Objective :To investigate the antibiotic resistance of Helicobacter pylori (H .pylori) isolated from patients in Western Guangdong .Methods :H .pylori was isolated from gastric mucosa biopsy specimens obtained from 600 pa-tients with chronic superficial gastritis or peptic ulcer disease in our hospital ,and then were cultured and identified . Additionally ,H .pylori strains were tested for drug resistance by Kirby-Bauer method .Results:The positive rate of iso-lated H .pylori strains was 78 .5% among 600 patients .The resistance rates for metronidazole ,clarithromycin ,levo-floxacin and amoxicillin were 77 .5% ,20 .4% ,8 .9% and 3 .2% respectively .Conclusion:The first-line antibiotic treat-ment for H .pylori infection in Western Guangdong should be amoxicillin and levofloxacin .In addition ,metronidazole was avoided in the treatment of H .pylori infection ,as well as clarithromycin which was used cautiously .%目的:了解粤西地区幽门螺杆菌(H .pylori)对抗生素的耐药情况。方法:选择我院确诊的慢性浅表性胃炎或消化性溃疡患者600例,取胃窦黏膜组织进行H .pylori培养鉴定,采用Kirby-Bauer纸片扩散法对分离菌株进行药敏检测。结果:H .pylori分离培养阳性率为78.5%;H .pylori对甲硝唑、克拉霉素、左氧氟沙星及阿莫西林的耐药率分别是77.5%、20.4%、8.9%和3.2%。结论:粤西地区H .pylori根除治疗的抗生素首选阿莫西林和左氧氟沙星,避免使用甲硝唑,慎重使用克拉霉素。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号